Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research

American Journal of Translational Research

Hideko Kamino¹  Judith D. Goldberg¹  Nina Bhardwaj¹  Anna Pavlick¹  Lindsay G. Wich¹  Prashiela Manga¹  Michelle Krogsgaard¹  David Polsky¹  Heather K. Hamilton¹  Harry Ostrer¹  Russell S. Berman¹  Peng Lee¹  Iman Osman¹  Richard L. Shapiro¹  Seth J. Orlow¹  Eva Hernando¹  Farbod Darvishian¹ 

关键词: Melanoma;    clinical database;    specimen bank;    translational medicine;    model;   

DOI  :  

学科分类：医学（综合）

来源: e-Century Publishing Corporation

【 摘 要 】

Several challenges face the development and operation of a biospecimen bank linked to clinical information, a critical component of any effective translational research program. Melanoma adds particular complexity and difficulty to such an endeavor considering the unique characteristics of this malignancy. We describe here a review of biospecimen bank and our experience in establishing a multi-disciplinary, prospective, integrated clinicopathological-biospecimen database in melanoma. The Interdisciplinary Melanoma Cooperative Group (IMCG), a prospective clinicopathological and biospecimen database, was established at the New York University (NYU) Langone Medical Center. With patients' informed consent, biospecimens from within and outside NYU, clinicopathological data, and follow-up information are collected using developed protocols. Information pertaining to biospecimens is recorded in 35 fields, and clinicopathological information is recorded in 371 fields within 5 modules in a virtual network system. Investigators conducting research utilizing the IMCG biospecimen resource are blind to clinicopathological information, and molecular data generated using biospecimens are linked independently with clinicopathological data by biostatistics investigators. This translational research enterprise acts as a valuable resource to efficiently translate laboratory discoveries to the clinic.

【 授权许可】

Unknown